Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Locally Recurrent Breast Cancer
- Metastatic Breast Cancer
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03786094
- Collaborators
- Not Provided
- Investigators
- Study Director: François Ringeisen, MD Polyphor Ltd. Principal Investigator: Peter A Kaufman, MD UVM medical center; USA Principal Investigator: Javier Cortes, MD IOB and VHIO; Spain
Get Well Soon